Display options
Share it on

Obstet Gynecol Int. 2010;2010:965905. doi: 10.1155/2010/965905. Epub 2010 Jul 08.

Study on the Imprinting Status of Insulin-Like Growth Factor II (IGF-II) Gene in Villus during 6-10 Gestational Weeks.

Obstetrics and gynecology international

Jianhong Chen, Qun Fang, Baojiang Chen, Yi Zhou, Yanmin Luo

Affiliations

  1. Department of Obstetrics and Gynecology, Fetal Medical Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510275, China.

PMID: 20671918 PMCID: PMC2910499 DOI: 10.1155/2010/965905

Abstract

Objective. To compare the difference of imprinting status of insulin-like growth factor II (IGF-II) gene in villus between normal embryo development group and abnormal embryo development group and to investigate the relationship between karyotype and the imprinting status of IGF-II gene. Methods. A total of 85 pregnant women with singleton pregnancy were divided into two groups: one with abnormal embryo development (n = 38) and the other with normal embryo development (n = 47). Apa I polymorphism of IGF-II gene in chorionic villus was assayed with reverse transcriptase polymerase chain reaction (RT-PCR) and restriction fragment length polymorphism (RFLP). The relationship between chromosomal abnormal karyotype and IGF-II gene imprinting status was analyzed by primary cell culture and G-banding chromosomal karyotype analysis. Results. IGF-II imprinting loss rate was higher in the abnormal embryo development group than the normal embryo development group (44.7% versus 31.6%), but without significant difference (P > .05). The percentage of abnormal chromosomes of chorionic villus in the abnormal embryo development group was 42.5%, in which IGF-II imprinting loss rate reached 64.7%. No abnormal karyotypes were found in the normal embryo development group. However, there was significant difference in IGF-II imprinting loss rate between two groups (P > .05). Conclusion. During weeks 6-10 of gestation, abnormal embryonic development is correlated with chromosomal abnormalities. The imprinting status of IGF-II gene played important roles in embryonic development, and imprinting loss might be related to chromosomal abnormalities.

References

  1. Clin Cancer Res. 2004 Dec 1;10(23):7950-7 - PubMed
  2. Growth Horm IGF Res. 2007 Apr;17(2):130-6 - PubMed
  3. Endocr Dev. 2009;14:20-8 - PubMed
  4. Chin Med J (Engl). 2004 Apr;117(4):488-91 - PubMed
  5. Obstet Gynecol. 2004 Oct;104(4):784-8 - PubMed
  6. J Clin Endocrinol Metab. 1995 May;80(5):1548-55 - PubMed
  7. Biochim Biophys Acta. 2002 Apr 24;1586(3):307-15 - PubMed
  8. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Jul;35(4):466-9 - PubMed
  9. Digestion. 1999 Sep-Oct;60(5):477-83 - PubMed
  10. Hum Reprod. 2002 Feb;17(2):452-6 - PubMed
  11. Hum Reprod. 1998 Jun;13 Suppl 3:178-90; discussion 191-6 - PubMed

Publication Types